HomeAuthorsPosts by Sam Atkinson

Sam Atkinson

SGX-LISTED COMPANIES

Top Glove Q3 FY2026 Earnings Rise Despite Fluctuating Material Costs

Resilient Growth and Strategic Agility Top Glove Corporation has reported a remarkable 138% year-on-year surge in profit for the third quarter ended May 31, 2026. This performance marks a decisive shift from a period of recovery toward a new phase of resilient growth in the...
Pharmaceutical

AstraZeneca invests US$20M to curb Malaysia chronic disease burden

AstraZeneca is scaling up early screening and clinical research efforts in Malaysia as the country grapples with a growing burden of non-communicable diseases (NCDs), particularly diabetes and chronic kidney disease. Recent estimates show that one-in-six Malaysians has diabetes, while one-in-seven is at risk of chronic...
spot_img

Keep exploring

SGX-LISTED COMPANIES

Keong Hong S$14 Million FY2025 Pivot

How Keong Hong Navigated the Construction "Death Zone" to Reclaim Profitability Introduction: The Construction Industry’s...
SGX-LISTED COMPANIES

How Mapletree Logistics Trust Defies Market Chaos With A 96% Success Strategy In Q3 FY25/26

The Silent Resilience: 4 Surprising Truths Hidden in Mapletree Logistics Trust’s Latest Financials In today’s...
SGX-LISTED COMPANIES

How OUE REIT’s Strategic Pivot Delivered A 15.7% Core DPU Surge In FY2025

Introduction: The Yield-Seeker’s Dilemma In a global macro environment characterized by terminal rate uncertainty and...
SGX-LISTED COMPANIES

The Assembly Place IPO — How One Company Is Quietly Redefining Urban Living

The "Un-Real Estate" Model The modern city is a paradox: more densely populated than ever,...
SGX-LISTED COMPANIES

Why This Rainforest Gold Miner Is Defying The Market

5 Surprising Takeaways from CNMC’s Expansion In a global market where high-growth dividend stocks are...
SGX-LISTED COMPANIES

Is Tiong Woon A $200M Giant Hiding In Plain Sight?

Why the World’s 15th Largest Crane Powerhouse is a "Laggard" Worth Watching In the high-octane...
SGX-LISTED COMPANIES

When AI Meets The Aquarium – Qian Hu Corporation FY2025

The High-Tech Future of Fish: 4 Surprising Takeaways from Qian Hu’s 2025 Results Introduction: In the...
SGX-LISTED COMPANIES

Why The ‘Boring’ Engineering Of Nordic Group Is The Smartest Play Of 2026

The 37% Upside Hiding in Plain Sight In an era of fragmenting global trade and...
SGX-LISTED COMPANIES

Toku Ltd.’s IPO — Can Asia-Pacific AI Outcompete Global Tech Incumbents?

Beyond Palo Alto: Why Toku’s Bet on "Linguistic Chaos" is Disrupting the $21B Contact...
SGX-LISTED COMPANIES

Why China Aviation Oil Is The Most Overlooked Story In Aviation

If you have stepped into an airport recently, you have seen it firsthand: terminals...
SGX-LISTED COMPANIES

Why Indonesia’s Chocolate King Is Defying The Cocoa Crisis

Bitter Costs, Sweet Returns The global chocolate market is currently navigating a "super-cycle" that feels...
SGX-LISTED COMPANIES

How Tosei Corp Mastered Strategic Deferral In FY2025 To Shatter Records In A Shifting Tokyo Market

In the high-stakes theater of global real estate, Tokyo has reinforced its standing as...
Load more

Latest articles

SGX-LISTED COMPANIES

Top Glove Q3 FY2026 Earnings Rise Despite Fluctuating Material Costs

Resilient Growth and Strategic Agility Top Glove Corporation has reported a remarkable 138% year-on-year surge...
Pharmaceutical

AstraZeneca invests US$20M to curb Malaysia chronic disease burden

AstraZeneca is scaling up early screening and clinical research efforts in Malaysia as the...
Pharmaceutical

AstraZeneca expands diagnostics and AI to tackle late-stage cancer deaths

AstraZeneca is sharpening its long-term AstraZeneca cancer strategy with a combination of heavy research...
Pharmaceutical

AstraZeneca deploys AI to cut drug timelines by 30% and boost survival

AstraZeneca is stepping up its investment in AI drug discovery to shorten treatment timelines...